Clinical Trial Update: A Post Marketing Surveillance to Evaluate the Safety and Efficacy of Brilinta

View source ↗

Summary

A post-marketing surveillance study to assess the safety and efficacy of Brilinta (ticagrelor) has been completed. The study focused on patients with Acute Coro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndromes

Drugs mentioned

• BRILINTA (ticagrelor)

Snippet

Sponsor: AstraZeneca | Conditions: Acute Coronary Syndromes | Status: COMPLETED